1Ahmed SF, Cheng A, Dovey L, et al.Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab, 2000,85: 658-665.
2Fentener-van Vlissingen JM, van Zoelen EJJ. In vitro model of the first phase of testicular descent: Identification of a low molecular weight factor from fetal testis involved in proliferation of gubernaculum testis cells and distinct from specified polypeptide growth factors and fetal gonadal hormones. Endocrinology, 1988, 123:2868-2877.
3Adham IM, Emmen JMA, Engel W. The role of the testicular factor INSL3 in establishing the gonadal position. Mol Cell Endocrinol, 2000, 160:11-16.
4Zimmermann S, Schottler P, Engel W, et al. Mouse Leydig insulin-like (Ley I-L) gene: structure and expression during testis and ovary development. Mol Reprod Dev, 1997, 47:30-38.
5Zimmermann S, Steding G, Emmen JM,et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol, 1999, 13:681-691.
6Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nat Genet, 1999, 22:295-299.
7Ito M, Yu R, Jameson JL. DAX-1 inhibits SF-1-mediated trans activation via a carboxy- terminal domain that is deleted in adrenal hypoplasia congenital. Mol Cell Biol, 1997, 17:1476-1483.
8Zimmermann S, Sehwarzler A, Buth S, et al. Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor-1. Mol Endocrinol, 1998, 12: 706-713.
9Koskimies P, Levallet J, Sipil P, et al. Murine Relaxin-Like Factor Promoter: Functional Characterization and Regulation by Transcription Factors Steroidogenic Factor 1 and DAX-1. Endocrinology, 2002,3: 909-9190.
10Overbeek PA, Gorlov IP, Sutherland RW,et al. A transgenic insertion causing cryptorchidism in mice. Genesis, 2001,30: 26-35.
同被引文献15
1Hideki T, Yasunari S, Jenny H, et al. Testicular descent, cryptorchidism and inguinal hernia: the Melbourne perspective. J Pediatr Surg Urol, 2005, 1 : 11-25.
2Sultan C, Balaguer P, Terouanne B, et al. Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation. Mol Cell Endocrinol, 2001, 178: 99-105.
3Gill WB, Schumacher GF, Bibbo M, et al. Association of diethylstilbestrolexposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol, 1979, 122: 36-39.
4Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol, 1982, 142: 905-921.
5Nef S, Shipman T, Parada LF. A molecular basis for estrogeninduced cryptorchidism. Dev Biol, 2000, 224: 354-361.
6Emmen JM, McLuskey A, Adham IM, et al. Involvement of insulin-like factor 3 ( Insl3 ) in diethylstilbestrol induced cryptorchidism. Endocrinology, 2000, 141 : 846-849.
7Pusch W, Balvers M, Ivell R. Molecular cloning and expression of the relaxin-like factor from the mouse testis. Endocrinology, 1996, 137: 3009-3013.
8Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nature Genetics, 1999, 22: 295-299.
9Zimmermann S, Steding G, Emmen JM, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol, 1999, 13: 681-691.
10Zimmermann S, Schwarzler A, Buth S, et al. Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor- 1. Mol Endocrinol, 1998, 12: 706-713.
